Otic drug delivery systems: formulation principles and recent developments

References

• Osguthorpe JD, Nielsen DR. Otitis externa: review and clinical update. Am Fam Physician. 2006;74:1510–1516.
   PubMed Web of Science ®Google Scholar
• Shekelle PG, Takata G, Newberry SJ, et al. Management of acute otitis media: update. Evid Rep Technol Assess (Full Rep). 2010;198:1–426.
   Google Scholar
• Coco AS. Cost-effectiveness analysis of treatment options for acute otitis media. Ann Fam Med. 2007;5:29–38.
   PubMed Web of Science ®Google Scholar
• Vio MM, Holme RH. Hearing loss and tinnitus: 250 million people and a US$10 billion potential market. Drug Discov Today. 2005;10:1263–1265.
   PubMed Web of Science ®Google Scholar
• Lin FR, Niparko JK, Ferrucci L. Hearing loss prevalence in the United States. Arch Intern Med. 2011;171:1851–1853.
   PubMed Web of Science ®Google Scholar
• Syed I, Aldren C. Meniere’s disease: an evidence based approach to assessment and management. Int J Clin Pract. 2012;66:166–170.
   PubMed Web of Science ®Google Scholar
• Meyer T. Intratympanic treatment for tinnitus: a review. Noise Health. 2013;15:83–90.
   PubMed Web of Science ®Google Scholar
• Ruckenstein MJ. Autoimmune inner ear disease. Curr Opin Otolaryngol Head Neck Surg. 2004;12:426–430.
   PubMedGoogle Scholar
• WHO.int [Internet]. New York: World Health Organization; 2018. Prevention of blindness and deafness. Available from: http://www.who.int/pbd/deafness/facts/en/.
   Google Scholar
• Esterberg R, Coffin AB, Ou H, et al. Fish in a dish: drug discovery for hearing habilitation. Drug Discov Today. 2013;10:e23–e29.
   Google Scholar
• Liu H, Hao J, Li KS. Current strategies for drug delivery to the inner ear. Acta Pharmaceutica Sinica B. 2013;3:86–96.
   Web of Science ®Google Scholar
• Valente F, Astolfi L, Simoni E, et al. Nanoparticle drug delivery systems for inner ear therapy: an overview. J Drug Deliv Sci Technol. 2017;39:28–35.
   Web of Science ®Google Scholar
• Fukui H, Raphael Y. Gene therapy for the inner ear. Hear Res. 2013;297:99–105.
   PubMed Web of Science ®Google Scholar
• Kojima K, Murata M, Nishio T, et al. Survival of fetal rat otocyst cells grafted into the damaged inner ear. Acta Oto-Laryngologica. 2004;124:53–55.
   PubMed Web of Science ®Google Scholar
• Harmes KM, Blackwood RA, Burrows HL, et al. Otitis media: diagnosis and treatment. Am Fam Physician. 2013;88:435–440.
   PubMed Web of Science ®Google Scholar
• Kaushik V, Malik T, Saeed SR. Interventions for acute otitis externa. Cochrane Database Syst Rev. 2010;1:Cd004740.
   Google Scholar
• Li L, Chao T, Brant J, et al. Advances in nano-based inner ear delivery systems for the treatment of sensorineural hearing loss. Adv Drug Deliv Rev. 2017;108:2–12.
   PubMed Web of Science ®Google Scholar
• Pyykko I, Zou J, Schrott-Fischer A, et al. An overview of nanoparticle based delivery for treatment of inner ear disorders. Methods Mol Biol. 2016;1427:363–415.
   PubMedGoogle Scholar
• Pyykkö I, Zou J, Zhang Y, et al. Nanoparticle-based delivery for the treatment of inner ear disorders. Curr Opin Otolaryngol Head Neck Surg. 2011;19:388–396.
   PubMed Web of Science ®Google Scholar
• Pritz CO, Roy S, Dudas J, et al. Nanomedicine strategies for drug delivery to the ear. Nanomedicine (Lond). 2013;8:1155–1172.
   PubMed Web of Science ®Google Scholar
• Chen G, Zhang X, Yang F, et al. Disposition of nanoparticle-based delivery system via inner ear administration. Curr Drug Metab. 2010;11:886–897.
   PubMed Web of Science ®Google Scholar
• Nguyen K, Kempfle JS, Jung DH, et al. Recent advances in therapeutics and drug delivery for the treatment of inner ear diseases: a patent review (2011–2015). Expert Opin Ther Pat. 2016;27:191–202.
   PubMed Web of Science ®Google Scholar
• El Kechai N, Mamelle E, Nguyen Y, et al. Hyaluronic acid liposomal gel sustains delivery of a corticoid to the inner ear. J Control Release. 2016;226:248–257.
   PubMed Web of Science ®Google Scholar
• Staecker H, Rodgers B. Developments in delivery of medications for inner ear disease. Expert Opin Drug Deliv. 2013;10:639–650.
   PubMed Web of Science ®Google Scholar
• Rivera T, Sanz L, Camarero G, et al. Drug delivery to the inner ear: strategies and their therapeutic implications for sensorineural hearing loss. Curr Drug Deliv. 2012;9:231–242.
   PubMed Web of Science ®Google Scholar
• Hoskison E, Daniel M, Al-Zahid S, et al. Drug delivery to the ear. Ther Deliv. 2012;4:115–124.
   Google Scholar
• Shibata SB, Raphael Y. Future approaches for inner ear protection and repair. J Commun Dis. 2010;43:295–310.
   Web of Science ®Google Scholar
• McCall AA, Swan EE, Borenstein JT, et al. Drug delivery for treatment of inner ear disease: current state of knowledge. Ear Hear. 2010;31:156.
   PubMed Web of Science ®Google Scholar
• Salt AN, Plontke SK. Principles of local drug delivery to the inner ear. Audiol Neurootol. 2009;14:350–360.
   PubMed Web of Science ®Google Scholar
• Paulson DP, Abuzeid W, Jiang H, et al. A novel controlled local drug delivery system for inner ear disease. Laryngoscope. 2008;118:706–711.
   PubMed Web of Science ®Google Scholar
• Alles MJRC, der Gaag MA, Stokroos RJ. Intratympanic steroid therapy for inner ear diseases, a review of the literature. Eur Arch Otorhinolaryngol. 2006;263:791–797.
   PubMed Web of Science ®Google Scholar
• Peppi M, Marie A, Belline C, et al. Intracochlear drug delivery systems: a novel approach whose time has come. Expert Opin Drug Deliv. 2018;15:319–324.
   PubMed Web of Science ®Google Scholar
• Ayoob AM, Borenstein JT. The role of intracochlear drug delivery devices in the management of inner ear disease. Expert Opinion Drug Deliv. 2015;12:465–479.
   PubMed Web of Science ®Google Scholar
• Borenstein JT. Intracochlear drug delivery systems. Expert Opin Drug Deliv. 2011;8:1161–1174.
   PubMed Web of Science ®Google Scholar
• Borkholder DA. State-of-the-art mechanisms of intracochlear drug delivery. Curr Opin Otolaryngol Head Neck Surg. 2008;16:472–477.
   PubMed Web of Science ®Google Scholar
• Pai Y-C, Lee C-F. Intratympanic steroid injection for inner ear disease. Tzu Chi Med J. 2013;25:146–149.
   Google Scholar
• Seggas I, Koltsidopoulos P, Bibas A, et al. Intratympanic steroid therapy for sudden hearing loss: a review of the literature. Otol Neurotol. 2011;32:29–35.
   PubMed Web of Science ®Google Scholar
• Herraiz C, Miguel Aparicio J, Plaza G. Intratympanic drug delivery for the treatment of inner ear diseases. Acta Otorrinolaringologica. 2010;61:225–232.
   PubMedGoogle Scholar
• Kohrman DC, Raphael Y. Gene therapy for deafness. Gene Ther. 2013;20:1119–1123.
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Ito J. Local drug delivery to the inner ear using biodegradable materials. Ther Deliv. 2011;2:807–814.
   PubMedGoogle Scholar
• Martinez Devesa P, Willis CM, Capper JWR. External auditory canal pH in chronic otitis externa. Clin Otolaryngol. 2003;28:320–324.
   PubMed Web of Science ®Google Scholar
• Kim JK, Cho JH. Change of external auditory canal pH in acute otitis externa. Ann Otol Rhinol Laryngol. 2009;118:769–772.
   PubMed Web of Science ®Google Scholar
• Ballachanda B. The human ear canal. San Diego (CA): Plural Publishing, Incorporated; 2013.
   Google Scholar
• Salvinelli F, Maurizi M, Calamita S, et al. The external ear and the tympanic membrane: a three-dimensional study. Scand Audiol. 1991;20:253–256.
   PubMed Web of Science ®Google Scholar
• Yang R, Wei T, Goldberg H, et al. Getting drugs across biological barriers. Adv Mater. 2017;29:1606596–160659.
   Web of Science ®Google Scholar
• Qureishi A, Lee Y, Belfield K, et al. Update on otitis media – prevention and treatment. Infect Drug Resist. 2014;7:15–24.
   PubMed Web of Science ®Google Scholar
• Salt AN, Hirose K. Communication pathways to and from the inner ear and their contributions to drug delivery. Hear Res. 2017;362:25–37.
   PubMed Web of Science ®Google Scholar
• Juhn SK. Barrier systems in the inner ear. Acta Oto-Laryngologica. 1988;105:79–83.
   Web of Science ®Google Scholar
• Carpenter AM, Muchow D, Goycoolea MV. Ultrastructural studies of the human round window membrane. Arch Otolaryngol Head Neck Surg. 1989;115:585–590.
   PubMedGoogle Scholar
• Becvarovski Z, Bojrab DI, Michaelides EM, et al. Round window gentamicin absorption: an in vivo human model. Laryngoscope. 2002;112:1610–1613.
   PubMed Web of Science ®Google Scholar
• Goycoolea MV, Lundman L. Round window membrane: structure function and permeability: a review. Microsc Res Tech. 1997;36:201–211.
   PubMed Web of Science ®Google Scholar
• Goycoolea MV. The round window membrane under normal and pathological conditions. Acta Otolaryngol Suppl. 1992;493:43–55.
   PubMedGoogle Scholar
• Duan M-l, Zhi-qiang C. Permeability of round window membrane and its role for drug delivery: our own findings and literature review. J Otol. 2009;4:34–43.
   Google Scholar
• Okuno H, Sando I. Anatomy of the round window: a histopathological study with a graphic reconstruction method. Acta Oto-Laryngologica. 1988;106:55–63.
   PubMed Web of Science ®Google Scholar
• Mikulec AA, Hartsock JJ, Salt AN. Permeability of the round window membrane is influenced by the composition of applied drug solutions and by common surgical procedures. Otol Neurotol. 2008;29:1020–1026.
   PubMed Web of Science ®Google Scholar
• Saijo S, Kimura RS. Distribution of HRP in the inner ear after injection into the middle ear cavity. Acta Otolaryngol. 1984;97:593–610.
   PubMed Web of Science ®Google Scholar
• Kang WS, Nguyen K, McKenna CE, et al. Intracochlear drug delivery through the oval window in fresh cadaveric human temporal bones. Otol Neurotol. 2016;37:218–222.
   PubMed Web of Science ®Google Scholar
• Swan EE, Mescher MJ, Sewell WF, et al. Inner ear drug delivery for auditory applications. Adv Drug Deliv Rev. 2008;60:1583–1599.
   PubMed Web of Science ®Google Scholar
• Shi X. Pathophysiology of the cochlear intrastrial fluid-blood barrier (review). Hear Res. 2016;338:52–63.
   PubMed Web of Science ®Google Scholar
• Fedorova OV, Shadrin GB. The current views of the treatment of diffuse external otitis. Vestn Otorinolaringol. 2016;81:51–53.
   PubMedGoogle Scholar
• Sander R. Otitis externa: a practical guide to treatment and prevention. Am Fam Physician. 2001;63:927–936.
   PubMed Web of Science ®Google Scholar
• Schaefer P, Baugh RF. Acute otitis externa: an update. Am Fam Physician. 2012;86:1055–1061.
   PubMed Web of Science ®Google Scholar
• Rosenfeld RM, Schwartz SR, Cannon CR, et al. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014;150:S1–S24.
   PubMed Web of Science ®Google Scholar
• Granath A. Recurrent acute otitis media: what are the options for treatment and prevention? Curr Otorhinolaryngol Rep. 2017;5:93–100.
   PubMedGoogle Scholar
• Lieberthal AS, Carroll AE, Chonmaitree T, et al. The diagnosis and management of acute otitis media. Pediatrics. 2013;131:e964–e999.
   PubMed Web of Science ®Google Scholar
• Rosenfeld RM, Shin JJ, Schwartz SR, et al. Clinical practice guideline: otitis media with effusion (update). Otolaryngol Head Neck Surg. 2016;154:S1–S41.
   PubMed Web of Science ®Google Scholar
• Daniel M, Chessman R, Al-Zahid S, et al. Biofilm eradication with biodegradable modified-release antibiotic pellets: a potential treatment for glue ear. Arch Otolaryngol Head Neck Surg. 2012;138:942–949.
   PubMedGoogle Scholar
• Feng L, Ward JA, Li SK, et al. Assessment of PLGA-PEG-PLGA copolymer hydrogel for sustained drug delivery in the ear. Curr Drug Deliv. 2014;11:279–286.
   PubMed Web of Science ®Google Scholar
• Cunningham LL, Tucci DL. Hearing loss in adults. N Engl J Med. 2017;377:2465–2473.
   PubMed Web of Science ®Google Scholar
• Atar O, Avraham KB. Therapeutics of hearing loss: expectations vs reality. Drug Discov Today. 2005;10:1323–1330.
   PubMed Web of Science ®Google Scholar
• Shargorodsky J, Curhan SG, Curhan GC, et al. Change in prevalence of hearing loss in us adolescents. JAMA. 2010;304:772–778.
   PubMed Web of Science ®Google Scholar
• Crowson MG, Hertzano R, Tucci DL. Emerging therapies for sensorineural hearing loss. Otol Neurotol. 2017;38:792–803.
   PubMed Web of Science ®Google Scholar
• Hill SL 3rd, Digges EN, Silverstein H. Long-term follow-up after gentamicin application via the Silverstein MicroWick in the treatment of Meniere’s disease. Ear Nose Throat J. 2006;85:494–496.
   PubMedGoogle Scholar
• Nakashima T, Naganawa S, Sugiura M, et al. Visualization of endolymphatic hydrops in patients with Meniere’s disease. Laryngoscope. 2007;117:415–420.
   PubMed Web of Science ®Google Scholar
• Kaltenbach JA. Tinnitus: models and mechanisms. Hear Res. 2011;276:52–60.
   PubMed Web of Science ®Google Scholar
• Garduno-Anaya MA, Couthino De Toledo H, Hinojosa GR, et al. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere’s disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg. 2005;133:285–294.
   PubMed Web of Science ®Google Scholar
• Bovo R, Aimoni C, Martini A. Immune-mediated inner ear disease. Acta Otolaryngol. 2006;126:1012–1021.
   PubMed Web of Science ®Google Scholar
• Alexander TH, Weisman MH, Derebery JM, et al. Safety of high-dose corticosteroids for the treatment of autoimmune inner ear disease. Otol Neurotol. 2009;30:443–448.
   PubMed Web of Science ®Google Scholar
• Subcommittee on management of acute otitis media. Diagnosis and management of acute otitis media. Pediatrics. 2004;113:1451–1465.
   PubMed Web of Science ®Google Scholar
• Okovityi SV, Ivkin D, Malygin SV. Drug therapy of otitis externa and otitis media. Vestn Otorinolaringol. 2012;1:52–56.
   Google Scholar
• Awad Z, Huins C, Pothier DD. Antivirals for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev. 2012;8:Cd006987.
   Google Scholar
• Gacek RR. Recovery of hearing in Meniere’s disease after antiviral treatment. Am J Otolaryngol. 2015;36:315–323.
   PubMed Web of Science ®Google Scholar
• Horie RT, Sakamoto T, Nakagawa T, et al. Sustained delivery of lidocaine into the cochlea using poly lactic/glycolic acid microparticles. Laryngoscope. 2010;120:377–383.
   PubMed Web of Science ®Google Scholar
• Dispenza F, De Stefano A, Costantino C, et al. Sudden sensorineural hearing loss: results of intratympanic steroids as salvage treatment. Am J Otolaryngol. 2013;34:296–300.
   PubMed Web of Science ®Google Scholar
• Blakley BW. Update on intratympanic gentamicin for Meniere’s disease. Laryngoscope. 2000;110:236–240.
   PubMed Web of Science ®Google Scholar
• Monsell EM, Cass SP, Rybak LP. Therapeutic use of aminoglycosides in Meniere’s disease. Otolaryngol Clin North Am. 1993;26:737–746.
   PubMed Web of Science ®Google Scholar
• Heman-Ackah SE, Juhn SK, Huang TC, et al. A combination antioxidant therapy prevents age-related hearing loss in C57BL/6 mice. Otolaryngol Head Neck Surg. 2010;143:429–434.
   PubMed Web of Science ®Google Scholar
• Clifford RE, Coleman JK, Balough BJ, et al. Low-dose D-methionine and N-acetyl-L-cysteine for protection from permanent noise-induced hearing loss in chinchillas. Otolaryngol Head Neck Surg. 2011;145:999–1006.
   PubMed Web of Science ®Google Scholar
• Suckfuell M, Lisowska G, Domka W, et al. Efficacy and safety of AM-111 in the treatment of acute sensorineural hearing loss: a double-blind, randomized, placebo-controlled phase II study. Otology & Neurotology. 2014;35:1317–1326.
   PubMed Web of Science ®Google Scholar
• Omotehara Y, Hakuba N, Hato N, et al. Protection against ischemic cochlear damage by intratympanic administration of AM-111. Otol Neurotol. 2011;32:1422–1427.
   PubMed Web of Science ®Google Scholar
• Salvi R, Lobarinas E, Sun W. Pharmacological treatments for tinnitus: new and old. Drugs Future. 2009;34:381–400.
   PubMed Web of Science ®Google Scholar
• Wenzel GI, Warnecke A, Stöver T, et al. Effects of extracochlear gacyclidine perfusion on tinnitus in humans: a case series. Eur Arch Otorhinolaryngol. 2010;267:691–699.
   PubMed Web of Science ®Google Scholar
• Mukherjea D, Rybak LP, Sheehan KE, et al. The design and screening of drugs to prevent acquired sensorineural hearing loss. Expert Opin Drug Discov. 2011;6:491–505.
   PubMed Web of Science ®Google Scholar
• El Kechai N, Agnely F, Mamelle E, et al. Recent advances in local drug delivery to the inner ear. Int J Pharm. 2015;494:83–101.
   PubMed Web of Science ®Google Scholar
• Pararas EEL, Borkholder DA, Borenstein JT. Microsystems technologies for drug delivery to the inner ear. Adv Drug Deliv Rev. 2012;64:1650–1660.
   PubMed Web of Science ®Google Scholar
• Acton QA. Otitis – advances in research and treatment: 2013 Edition: ScholarlyBrief. 2013: Scholarly Editions.
   Google Scholar
• Rauch SD, Halpin CF, Antonelli PJ, et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA. 2011;305:2071–2079.
   PubMed Web of Science ®Google Scholar
• Kakehata S, Sasaki A, Oji K, et al. Comparison of intratympanic and intravenous dexamethasone treatment on sudden sensorineural hearing loss with diabetes. Otol Neurotol. 2006;27:604–608.
   PubMed Web of Science ®Google Scholar
• Shea PF, Richey PA, Wan JY, et al. Hearing results and quality of life after streptomycin/dexamethasone perfusion for Meniere’s disease. Laryngoscope. 2012;122:204–211.
   PubMed Web of Science ®Google Scholar
• Horie RT, Sakamoto T, Nakagawa T, et al. Stealth-nanoparticle strategy for enhancing the efficacy of steroids in mice with noise-induced hearing loss. Nanomedicine. 2010;5:1331–1340.
   PubMed Web of Science ®Google Scholar
• Sun C, Wang X, Chen D, et al. Dexamethasone loaded nanoparticles exert protective effects against Cisplatin-induced hearing loss by systemic administration. Neurosci Lett. 2016;619:142–148.
   PubMed Web of Science ®Google Scholar
• Eng CY, El-Hawrani AS. The pH of commonly used topical ear drops in the treatment of otitis externa. Ear Nose Throat J. 2011;90:160–162.
   PubMed Web of Science ®Google Scholar
• Khoo X, Simons EJ, Chiang HH, et al. Formulations for trans-tympanic antibiotic delivery. Biomaterials. 2013;34:1281–1288.
   PubMed Web of Science ®Google Scholar
• Marom T, Yelin R, Goldfarb A, et al. Comparison of safety and efficacy of foam-based versus solution-based ciprofloxacin for acute otitis externa. Otolaryngol Head Neck Surg. 2010;143:492–499.
   PubMed Web of Science ®Google Scholar
• Rosenfeld RM, Singer M, Wasserman JM, et al. Systematic review of topical antimicrobial therapy for acute otitis externa. Otolaryngol Head Neck Surg. 2006;134:S24–S48.
   PubMed Web of Science ®Google Scholar
• Haynes DS. Topical antibiotics: strategies for avoiding ototoxicity. Ear Nose Throat J. 2004;83:12–14.
   PubMedGoogle Scholar
• Yang R, Sabharwal V, Okonkwo OS, et al. Treatment of otitis media by transtympanic delivery of antibiotics. Sci Transl Med. 2016;8:356ra120–356ra120.
   PubMed Web of Science ®Google Scholar
• Shapiro B, Kulkarni S, Nacev A, et al. Shaping magnetic fields to direct therapy to ears and eyes. Annu Rev Biomed Eng. 2014;16:455–481.
   PubMed Web of Science ®Google Scholar
• Kurabi A, Beasley KA, Chang L, et al. Discovery of a biological mechanism of active transport through the tympanic membrane to the middle ear. Sci Rep. 2016;6:22663.
   PubMed Web of Science ®Google Scholar
• Kurabi A, Beasley KA, Chang L, et al. Peptides actively transported across the tympanic membrane: functional and structural properties. PLos One. 2017;12:e0172158.
   PubMed Web of Science ®Google Scholar
• Wang X, Dellamary L, Fernandez R, et al. Principles of inner ear sustained release following intratympanic administration. Laryngoscope. 2011;121:385–391.
   PubMed Web of Science ®Google Scholar
• Bowe SN, Jacob A. Round window perfusion dynamics: implications for intracochlear therapy. Curr Opin Otolaryngo Head Neck Surg. 2010;18:377–385.
   PubMed Web of Science ®Google Scholar
• Lajud SA, Han Z, Chi FL, et al. A regulated delivery system for inner ear drug application. J Control Release. 2013;166:268–276.
   PubMed Web of Science ®Google Scholar
• Yoon JY, Yang KJ, Kim DE, et al. Intratympanic delivery of oligoarginine-conjugated nanoparticles as a gene (or drug) carrier to the inner ear. Biomaterials. 2015;73:243–253.
   PubMed Web of Science ®Google Scholar
• Sellick P, Layton MG, Rodger J, et al. A method for introducing non-silencing siRNA into the guinea pig cochlea in vivo. J Neurosci Method. 2008;167:237–245.
   PubMed Web of Science ®Google Scholar
• Plontke SK, Hartsock JJ, Gill RM, et al. Intracochlear drug injections through the round window membrane: measures to improve drug retention. Audiol Neurotol. 2016;21:72–79.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Kysar JW, Lalwani AK. Round window membrane as a portal for inner ear therapy. Recent Adv Otolaryngol Head Neck Surg. 2017;6:39.
   Google Scholar
• Wazen JM, Stevens JP, Watanabe H, et al. Silver/silver chloride microneedles can detect penetration through the round window membrane. J Biomed Mater Res. 2017;105:307–311.
   Web of Science ®Google Scholar
• Lee JJ, Jang JH, Choo OS, et al. Steroid intracochlear distribution differs by administration method: systemic versus intratympanic injection. Laryngoscope. 2018;128:189–194.
   PubMed Web of Science ®Google Scholar
• Salt AN, Plontke SK. Pharmacokinetic principles in the inner ear: influence of drug properties on intratympanic applications. Hear Res. 2018;1:1–13.
   Google Scholar
• Havenith S, Versnel H, Agterberg MJ, et al. Spiral ganglion cell survival after round window membrane application of brain-derived neurotrophic factor using gelfoam as carrier. Hear Res. 2011;272:168–177.
   PubMed Web of Science ®Google Scholar
• Engleder E, Honeder C, Klobasa J, et al. Preclinical evaluation of thermoreversible triamcinolone acetonide hydrogels for drug delivery to the inner ear. Int J Pharm. 2014;471:297–302.
   PubMed Web of Science ®Google Scholar
• Sidell D, Ward JA, Pordal A, et al. Combination therapies using an intratympanic polymer gel delivery system in the guinea pig animal model: a safety study. Int J Pediatr Otorhinolaryngol. 2016;84:132–136.
   PubMed Web of Science ®Google Scholar
• Salt AN, Gill RM, Plontke SK. Dependence of hearing changes on the dose of intratympanically-applied gentamicin: a meta-analysis using mathematical simulations of clinical drug delivery protocols. Laryngoscope. 2008;118:1793–1800.
   PubMed Web of Science ®Google Scholar
• Salt AN, Hartsock JJ, Plontke SK, et al. Distribution of dexamethasone and preservation of inner ear function following intratympanic delivery of a gel-based formulation. Audiol Neurotol. 2011;16:323–335.
   PubMed Web of Science ®Google Scholar
• Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomed. 2015;10:975–999.
   PubMed Web of Science ®Google Scholar
• Roy S, Glueckert R, Johnston AH, et al. Strategies for drug delivery to the human inner ear by multifunctional nanoparticles. Nanomedicine. 2011;7:55–63.
   PubMed Web of Science ®Google Scholar
• Cai H, Wen X, Wen L, et al. Enhanced local bioavailability of single or compound drugs delivery to the inner ear through application of PLGA nanoparticles via round window administration. Int J Nanomed. 2014;9:5591.
   PubMed Web of Science ®Google Scholar
• Kim D-K, Park SN, Park KH, et al. Development of a drug delivery system for the inner ear using poly(amino acid)-based nanoparticles. Drug Deliv. 2015;22:367–374.
   PubMed Web of Science ®Google Scholar
• Hahn H, Salt AN, Biegner T, et al. Dexamethasone levels and base to apex concentration gradients in scala tympani perilymph following intracochlear delivery in the guinea pig. Otol Neurotol. 2012;33:660–665.
   PubMed Web of Science ®Google Scholar
• Plontke SK, Gotze G, Rahne T, et al. Intracochlear drug delivery in combination with cochlear implants: current aspects. HNO. 2017;65:19–28.
   PubMed Web of Science ®Google Scholar
• Mittal R, Nguyen D, Patel AP, et al. Recent advancements in the regeneration of auditory hair cells and hearing restoration. Front Mol Neurosci. 2017;10:236.
   PubMed Web of Science ®Google Scholar
• Tom LWC. Ototoxicity of common topical antimycotic preparations. Laryngoscope. 2000;110:509–516.
   PubMed Web of Science ®Google Scholar
• Wang KW. Bailey’s head and neck surgery: otolaryngology. Philadephia (PA): Lippincott Williams & Wilkins; 2013.
   Google Scholar
• Vural A, Şahin Mİ, Aydın M, et al. The effect of nystatin solution on otoacoustic emissions in rats. J Int Adv Otol. 2017;13:105–109.
   PubMed Web of Science ®Google Scholar
• Roland PS, Rutka JA. Ototoxicity. Raleigh (NC): PMPH-USA; 2004.
   Google Scholar
• Roland PS. Characteristics of systemic and topical agents implicated in toxicity of the middle and inner ear. Ear Nose Throat J. 2003;82:3.
   PubMedGoogle Scholar
• Taneja MK, Varshney H, Taneja V, et al. Ototoxicity, drugs, chemicals, mobile phones and deafness. Indian J Otol. 2015;21:161–164.
   Web of Science ®Google Scholar
• Haynes DS, Rutka J, Hawke M, et al. Ototoxicity of ototopical drops-an update. Otolaryngol Clin North Am. 2007;40:669–683.
   PubMed Web of Science ®Google Scholar
• Waissbluth S, Daniel SJ. Cisplatin-induced ototoxicity: transporters playing a role in cisplatin toxicity. Hearing Res. 2013;299:37–45.
   PubMed Web of Science ®Google Scholar
• Xie J, Talaska AE, Schacht J. New developments in aminoglycoside therapy and ototoxicity. Hear Res. 2011;281:28–37.
   PubMed Web of Science ®Google Scholar
• Selimoglu E. Aminoglycoside-induced ototoxicity. Curr Pharm Des. 2007;13:119–126.
   PubMed Web of Science ®Google Scholar
• Paken J, Govender CD, Paken J, et al. Cisplatin-associated ototoxicity: a review for the health professional. J Toxicol. 2016;2016:13.
   Google Scholar
• Rybak LP, Ramkumar V. Ototoxicity. Kidney Int. 2007;72:931–935.
   PubMed Web of Science ®Google Scholar
• Rybak LP, Whitworth CA. Ototoxicity: therapeutic opportunities. Drug Discov Today. 2005;10:1313–1321.
   PubMed Web of Science ®Google Scholar
• Gianoli GJ, Li JC. Transtympanic steroids for treatment of sudden hearing loss. Otolaryngol Head Neck Surg. 2001;125:142–146.
   PubMed Web of Science ®Google Scholar
• O’Sullivan ME, Perez A, Lin R, et al. Towards the prevention of aminoglycoside-related hearing loss. Front Cell Neurosci. 2017;11:325.
   PubMed Web of Science ®Google Scholar
• Karasawa T, Steyger PS. An integrated view of cisplatin-induced nephrotoxicity and ototoxicity. Toxicol Lett. 2015;237:219–227.
   PubMed Web of Science ®Google Scholar
• Goodall AF, Siddiq MA. Current understanding of the pathogenesis of autoimmune inner ear disease: a review. Clin Otolaryngol. 2015;40:412–419.
   PubMed Web of Science ®Google Scholar
• Yu D, Sun C, Zheng Z, et al. Inner ear delivery of dexamethasone using injectable silk-polyethylene glycol (PEG) hydrogel. Int J Pharm. 2016;503:229–237.
   PubMed Web of Science ®Google Scholar
• Liu H, Feng L, Tolia G, et al. Evaluation of intratympanic formulations for inner ear delivery: methodology and sustained release formulation testing. Drug Dev Ind Pharm. 2014;40:896–903.
   PubMed Web of Science ®Google Scholar
• Kanzaki S, Fujioka M, Yasuda A, et al. Novel in vivo imaging analysis of an inner ear drug delivery system in mice: comparison of inner ear drug concentrations over time after transtympanic and systemic injections. PLos One. 2012;7:e48480.
   PubMed Web of Science ®Google Scholar
• Ryan AF, Harris JP, Keithley EM. Immune-mediated hearing loss: basic mechanisms and options for therapy. Acta Otolaryngol Suppl. 2002;122:38–43.
   Google Scholar
• Holley MC. Keynote review: the auditory system, hearing loss and potential targets for drug development. Drug Discov Today. 2005;10:1269–1282.
   PubMed Web of Science ®Google Scholar
• De Paolis A, Watanabe H, Nelson JT, et al. Human cochlear hydrodynamics: a high-resolution μCT-based finite element study. J Biomech. 2017;50:209–216.
   PubMed Web of Science ®Google Scholar
• Salt AN, Plontke SKR. Local inner-ear drug delivery and pharmacokinetics. Drug Discov Today. 2005;10:1299–1306.
   PubMed Web of Science ®Google Scholar
• Sakamoto T, Nakagawa T, Horie RT, et al. Inner ear drug delivery system from the clinical point of view. Acta Oto-Laryngologica. 2010;130:101–104.
   Web of Science ®Google Scholar
• Liebau A, Pogorzelski O, Salt AN, et al. Hearing changes after intratympanically applied steroids for primary therapy of sudden hearing loss: a meta-analysis using mathematical simulations of drug delivery protocols. Otol Neurotol. 2017;38:19–30.
   PubMed Web of Science ®Google Scholar
• Plontke S, Siedow N, Hahn H, et al. 1D- and 3D-computer simulation for experimental planning and interpretation of pharmacokinetic studies in the inner ear after local drug delivery. Altex. 2004;21:77–85.
   PubMedGoogle Scholar
• Salt AN, Plontke SK. Endolymphatic hydrops: pathophysiology and experimental models. Otolaryngol Clin North Am. 2010;43:971–983.
   PubMed Web of Science ®Google Scholar
• Plontke SKR, Salt AN. Quantitative interpretation of corticosteroid pharmacokinetics in inner fluids using computer simulations. Hear Res. 2003;182:34–42.
   PubMed Web of Science ®Google Scholar
• Salt AN. Simulation of methods for drug delivery to the cochlear fluids. In: Felix D, Oestreicher E, editors. Rational pharmacotherapy of the inner ear. Basel (Switzerland): Karger Publishers; 2002. p. 140–148.
   Google Scholar